Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 1
2014 1
2016 1
2020 7
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study.
Guidelli GM, Viapiana O, Luciano N, De Santis M, Boffini N, Quartuccio L, Birra D, Conticini E, Chimenti MS, Bazzani C, Bruschi E, Riva M, Canziani LM, Bianchi G, Pozzi MR, Limonta M, Gorla R, Perricone R, Frediani B, Moscato P, De Vita S, Dagna L, Rossini M, Selmi C. Guidelli GM, et al. Among authors: boffini n. Clin Exp Rheumatol. 2021 Jul-Aug;39(4):868-873. Epub 2020 Dec 18. Clin Exp Rheumatol. 2021. PMID: 33338001
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study.
Campochiaro C, Della-Torre E, Cavalli G, De Luca G, Ripa M, Boffini N, Tomelleri A, Baldissera E, Rovere-Querini P, Ruggeri A, Monti G, De Cobelli F, Zangrillo A, Tresoldi M, Castagna A, Dagna L; TOCI-RAF Study Group. Campochiaro C, et al. Among authors: boffini n. Eur J Intern Med. 2020 Jun;76:43-49. doi: 10.1016/j.ejim.2020.05.021. Epub 2020 May 22. Eur J Intern Med. 2020. PMID: 32482597 Free PMC article.
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.
Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D, Oltolini C, Castiglioni B, Tassan Din C, Boffini N, Tomelleri A, Farina N, Ruggeri A, Rovere-Querini P, Di Lucca G, Martinenghi S, Scotti R, Tresoldi M, Ciceri F, Landoni G, Zangrillo A, Scarpellini P, Dagna L. Cavalli G, et al. Among authors: boffini n. Lancet Rheumatol. 2020 Jun;2(6):e325-e331. doi: 10.1016/S2665-9913(20)30127-2. Epub 2020 May 7. Lancet Rheumatol. 2020. PMID: 32501454 Free PMC article.
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation.
Della-Torre E, Lanzillotta M, Campochiaro C, Cavalli G, De Luca G, Tomelleri A, Boffini N, De Lorenzo R, Ruggeri A, Rovere-Querini P, Castagna A, Landoni G, Tresoldi M, Ciceri F, Zangrillo A, Dagna L. Della-Torre E, et al. Among authors: boffini n. Front Immunol. 2021 Apr 29;12:675678. doi: 10.3389/fimmu.2021.675678. eCollection 2021. Front Immunol. 2021. PMID: 33995419 Free PMC article. Clinical Trial.
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study.
Cavalli G, Larcher A, Tomelleri A, Campochiaro C, Della-Torre E, De Luca G, Farina N, Boffini N, Ruggeri A, Poli A, Scarpellini P, Rovere-Querini P, Tresoldi M, Salonia A, Montorsi F, Landoni G, Castagna A, Ciceri F, Zangrillo A, Dagna L. Cavalli G, et al. Among authors: boffini n. Lancet Rheumatol. 2021 Apr;3(4):e253-e261. doi: 10.1016/S2665-9913(21)00012-6. Epub 2021 Feb 3. Lancet Rheumatol. 2021. PMID: 33655218 Free PMC article.
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study.
Della-Torre E, Campochiaro C, Cavalli G, De Luca G, Napolitano A, La Marca S, Boffini N, Da Prat V, Di Terlizzi G, Lanzillotta M, Rovere Querini P, Ruggeri A, Landoni G, Tresoldi M, Ciceri F, Zangrillo A, De Cobelli F, Dagna L; SARI-RAF Study Group; SARI-RAF Study Group members. Della-Torre E, et al. Among authors: boffini n. Ann Rheum Dis. 2020 Oct;79(10):1277-1285. doi: 10.1136/annrheumdis-2020-218122. Epub 2020 Jul 3. Ann Rheum Dis. 2020. PMID: 32620597 Free PMC article.
13 results